Chloroform → HCID 88040420, compound
Reaction equation
O[O:2][S:3]([O-:5])=O.[K+].[CH2:7]([N:14]1[C@@H:19]2[C@H:20]([C:22]3[N:23]=[N:24][N:25]([CH2:27]SC)[N:26]=3)[CH2:21][C@@:15]1([C:46]1[CH:51]=[CH:50][CH:49]=[CH:48][CH:47]=1)[C@H:16]([O:30][CH2:31][C:32]1[CH:37]=[C:36]([C:38]([F:41])([F:40])[F:39])[CH:35]=[C:34]([C:42]([F:45])([F:44])[F:43])[CH:33]=1)[CH2:17][CH2:18]2)[C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1.[CH:52](Cl)(Cl)Cl>>[CH2:7]([N:14]1[C@@H:19]2[C@H:20]([C:22]3[N:23]=[N:24][N:25]([CH2:27][S:3]([CH3:52])(=[O:5])=[O:2])[N:26]=3)[CH2:21][C@@:15]1([C:46]1[CH:51]=[CH:50][CH:49]=[CH:48][CH:47]=1)[C@H:16]([O:30][CH2:31][C:32]1[CH:37]=[C:36]([C:38]([F:39])([F:40])[F:41])[CH:35]=[C:34]([C:42]([F:44])([F:45])[F:43])[CH:33]=1)[CH2:17][CH2:18]2)[C:8]1[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=1Participants
4
Conditions
- Temperature
- 50 °C
Procedure
Oxone® (370 mg, 0.6 mmol) was added to a suspension of (1R*,2R*,5S*,6R*)-8-benzyl-2-{[3,5-bis(trifluoromethyl)phenyl]methoxy}-6-(2-methylthiomethyl-2H-tetrazol-5-yl)-1-phenyl-8-azabicyclo[3.2.1]octane (Compound 3 g in Table 3; 130 mg, 0.2 mmol) and wet alumina (200 mg) in chloroform (10 ml). The mixture was heated to 50° C. for 18 hours, then filtered through Celite™ and the filtrate concentrated in vacuo to yield the title compound (92 mg, 68%).
Workup
- filtrationfiltered through Celite™
- concentrationthe filtrate concentrated in vacuo
Sources & evidence
- ORD record
- ord-96fb7aea061b4284900385b4ea2276ee
- Source dataset
- uspto-grants-2004_04
- Patent number
- US06727249B2
Reaction notes
Loading…